C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2009
12/24/2009	US20090318472 Aminopyrazine derivatives and compositions
12/24/2009	US20090318471 New Salts and Crystalline Salt Forms of an Indolinone Derivative
12/24/2009	US20090318470 1-substituted-3-(naphthalen-1-ylsulfonyl)-5-(piperazin-1-yl)-1h-indazole compounds as 5-hydroxytryptamine-6 ligands
12/24/2009	US20090318468 Pyrazole compounds 436
12/24/2009	US20090318463 Indolylmaleimide Derivatives
12/24/2009	US20090318448 Inhibitors of Bruton's Tyrosine Kinase
12/24/2009	US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
12/24/2009	US20090318445 Pdf inhibitors
12/24/2009	US20090318407 Inhibitors of protein kinases
12/24/2009	US20090318405 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/24/2009	US20090318373 Receptor-type kinase modulators and methods of use
12/23/2009	WO2009155527A2 Phosphatidylinositol 3 kinase inhibitors
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009155001A2 Wnt protein signalling inhibitors
12/23/2009	WO2009153569A2 Cb1 receptor modulators
12/23/2009	WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	WO2009153191A1 Novel Microbiocides
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153178A2 Aryl ketone as mri
12/23/2009	WO2009152995A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
12/23/2009	WO2009152825A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
12/23/2009	WO2009126863A3 Pyridyl inhibitors of hedgehog signalling
12/23/2009	WO2009097682A8 Anti-influenza compounds
12/23/2009	WO2008155140A8 Alkynylpyrimidines as tie2 kinase inhibitors
12/23/2009	WO2008142550A8 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
12/23/2009	EP2135865A1 Substituted 1-(diazinyl)pyrazol-4-yl acetic acids, method for their production and their use as herbicides and plant growth regulators
12/23/2009	EP2134706A2 Improved process for preparing irbesartan
12/23/2009	EP2134705A1 Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
12/23/2009	EP2134695A1 Inhibitors of the hedgehog pathway
12/23/2009	EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009	EP2134685A1 7-nonsubstituted indole mcl-1 inhibitors
12/23/2009	EP2134683A2 Novel inhibitors hepatitis c virus replication
12/23/2009	EP2134342A2 Monocyclic anilide spirolactam cgrp receptor antagonists
12/23/2009	EP2134176A1 Compounds and methods for enhancing mhc class ii therapies
12/23/2009	EP2134175A1 Inhibitors of akt activity
12/23/2009	EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009	CN101611030A Pyrimidinyl pyrazoles as insecticides and parasiticide active agents
12/23/2009	CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity
12/23/2009	CN101611016A Talarazole metabolites
12/23/2009	CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
12/23/2009	CN101611014A Acylaminopyrazoles as FGFR inhibitors
12/23/2009	CN101611002A 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
12/23/2009	CN101610998A 5 -amido- (ih- indol- 2 -yl) piperazin-1-yl-methanone derivatives as histamine h3 receptor ligands
12/23/2009	CN101607958A Quinazoline compounds
12/23/2009	CA2728408A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
12/23/2009	CA2728376A1 6-1h-imidazo-quinazoline and quinolines derivatives/mao inhibitors for treating depression
12/23/2009	CA2728373A1 Aryl ketone as mri
12/23/2009	CA2728335A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
12/23/2009	CA2728205A1 Substituted 1-(diazinyl)pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
12/23/2009	CA2728054A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	CA2726164A1 Wnt protein signalling inhibitors
12/22/2009	US7635781 Cyclopentadifuran derivatives; for preparation of catalyst components in the polymerization of olefins, particularly in the production of homo and copolymers of ethylene
12/22/2009	US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635701 Pyrimidine derivatives and their use as CB2 modulators
12/22/2009	US7635664 For controlling undesirable plants
12/22/2009	CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009	CA2434813C Imidazole derivatives
12/22/2009	CA2423806C Modified carbocyanine dyes and their conjugates
12/22/2009	CA2362381C Amide compounds and medicinal use thereof
12/22/2009	CA2290744C Cyclic diamine compounds and medicine containing the same
12/17/2009	WO2009152082A1 Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors
12/17/2009	WO2009151899A2 Preparation of imatinib mesylate
12/17/2009	WO2009151189A1 Process for preparing intermediate compound for synthesizing an antiulcerant
12/17/2009	WO2009151016A1 Method for producing 1-biphenylmethylimidazole compound
12/17/2009	WO2009150614A1 Tetrazole compounds as orexin receptor antagonists
12/17/2009	WO2009150523A1 Process for preparing a 3-pyrrole substituted 2-indolinone malate salt
12/17/2009	WO2009150462A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009	WO2009150007A1 Angiotensin ii receptor antagonists
12/17/2009	WO2009149734A1 Process for the preparation of irbesartan and intermediate products
12/17/2009	WO2009126947A3 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
12/17/2009	WO2009126315A3 Macrocyclic compounds and methods of treatment
12/17/2009	US20090312543 Pyrazole compounds useful as protein kinase inhibitors
12/17/2009	US20090312520 Triazine-Based Monomeric Compound, Di-Triazine Compound, and Degradable Polymer
12/17/2009	US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
12/17/2009	US20090312383 Fused Heterocyclic Compounds
12/17/2009	US20090312379 Dimeric Small Molecule Potentiators of Apoptosis
12/17/2009	US20090312375 Heterocyclic compounds, compositions comprising them and methods of their use
12/17/2009	US20090312366 Novel p2x7r antagonists and their use
12/17/2009	US20090312365 Certain Chemical Entities, Compositions, and Methods
12/17/2009	US20090312344 Arylpiperazine derivatives as adrenergic receptor antagonists
12/17/2009	US20090312342 Quinazolines useful as modulators of ion channels
12/17/2009	US20090312341 Cyclic amine bace-1 inhibitors having a heterocyclic substituent
12/17/2009	US20090312339 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group
12/17/2009	US20090312333 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
12/17/2009	US20090312327 Pyrrolidine derivatives as nk2 receptor antagonists
12/17/2009	US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors
12/17/2009	US20090312323 Compounds for the treatment of spinal muscular atrophy and other uses
12/17/2009	US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3
12/17/2009	US20090312309 Novel Medicaments
12/17/2009	US20090312307 Heterocyclo inhibitors of potassium channel function
12/17/2009	US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy
12/17/2009	US20090311217 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/17/2009	CA2727684A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor
12/17/2009	CA2727245A1 Imidazole derivatives useful as inhibitors of faah
12/17/2009	CA2727242A1 Pyrazole derivatives useful as inhibitors of faah
12/17/2009	CA2727220A1 Method for producing a 1-biphenylmethylimidazole compound
12/17/2009	CA2727073A1 Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
12/17/2009	CA2726102A1 Tetrazole compounds as orexin receptor antagonists

1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 626